FDA Inspection 1206106 — Clinigenix Ltd
The FDA completed an inspection of Clinigenix Ltd on April 21, 2023 in Noida. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Noida (India)
Additional Details
Bioanalytical BA/BE